Mianling Yang

发表

Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles

E. De Clercq, Dongwei Kang, C. Pannecouque, 2023, Acta pharmaceutica Sinica. B.

Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors

Dongwei Kang, P. Zhan, Xinyong Liu, 2022, Journal of medicinal chemistry.

Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors

Dongwei Kang, P. Zhan, Xinyong Liu, 2023, Acta pharmaceutica Sinica. B.

Jun12682, a potent SARS-CoV-2 papain-like protease inhibitor with exceptional antiviral efficacy in mice

Meehyein Kim, Mianling Yang, Peng Zhan, 2024, Acta Pharmaceutica Sinica B.